Related Experiment Videos
[Effect of gentamycin on persistence of tick-borne encephalitis]
Abstract:
Effect of gentamicin, an aminoglycoside antibiotic, on the persistence of tick-borne encephalitis (TBE) virus in Syrian hamsters and Macaca iris in remote periods (70-434 days) after inoculation is studied. Attempts at virus isolation from animals treated with gentamicin failed. Unlike other aminoglycosides, e.g. streptomycin, gentamicin exerted no immunodepressive effect; moreover, immunocorrection was observed in some experiments on monkeys and hamsters. None of the 10 previously tested antibiotics elicited such an effect or inhibited the persisting TBE virus. Morphological study of the central nervous system in hamsters and monkeys showed that injection of gentamicin did not cause an exacerbation of chronic encephalitis. The mechanism of immunocorrecting effect of gentamicin is to be further investigated.
Insights
Gentamicin, an antibiotic, successfully inhibited persistent tick-borne encephalitis (TBE) virus in animal models without causing immunosuppression. This antibiotic also showed a unique immunocorrecting effect, warranting further investigation.
Area of Science:
- Virology
- Immunology
- Pharmacology
Context:
- Tick-borne encephalitis (TBE) virus poses a significant public health challenge, often establishing persistent infections.
- Current treatments for persistent TBE virus infections are limited, highlighting the need for novel therapeutic strategies.
- Aminoglycoside antibiotics are widely used, but their effects on persistent viral infections and the immune system require further elucidation.
Purpose:
- To investigate the efficacy of gentamicin, an aminoglycoside antibiotic, in eliminating persistent tick-borne encephalitis (TBE) virus in vivo.
- To assess the impact of gentamicin on the immune status of animals infected with TBE virus.
- To evaluate the safety of gentamicin in the context of chronic TBE virus encephalitis.
Summary:
- Gentamicin treatment prevented TBE virus isolation from Syrian hamsters and Macaca iris during remote periods post-inoculation (70-434 days).
- Unlike streptomycin, gentamicin did not exhibit immunosuppressive effects and, in some cases, demonstrated an immunocorrecting influence in both hamsters and monkeys.
- Morphological studies of the central nervous system revealed no exacerbation of chronic encephalitis following gentamicin administration, distinguishing it from other antibiotics tested.
Impact:
- Gentamicin demonstrates potential as a novel therapeutic agent against persistent TBE virus infections.
- The observed immunocorrecting effect of gentamicin offers a unique therapeutic advantage, potentially mitigating disease severity.
- Further research into the mechanism of gentamicin's immunomodulatory properties could lead to broader applications in treating persistent viral infections.